Merck KGaA selects Veeva Vault CRM for global commercial operations
Get Alerts VEEV Hot Sheet
Join SI Premium – FREE
Veeva Systems (NYSE: VEEV) announced that Merck KGaA, Darmstadt, Germany, has committed to implementing Veeva Vault CRM across its global operations.
The customer relationship management system will integrate into Merck KGaA's data-driven ecosystem to support consistent processes and data connectivity across business functions, according to the companies' statements.
"We continue to work with Veeva as part of our ongoing digital initiatives," said Michael Motz, CIO Healthcare at Merck KGaA. "Veeva Vault integrates into our broader data‑driven ecosystem, supporting consistent processes and data connectivity across functions while allowing flexibility as our operating model evolves."
Vault CRM is part of Veeva's CRM Suite of applications designed for commercial execution in the life sciences industry. The platform includes AI capabilities through Vault AI for CRM, which provides multiple AI agents intended to drive commercial efficiency.
Chris Moore, president of Veeva Europe, stated the collaboration continues the company's work with Merck KGaA's Healthcare Business, with the CRM system enabling customer centricity and AI integration within workflows.
Veeva Systems provides cloud-based software solutions for the life sciences industry, serving more than 1,500 customers ranging from large biopharmaceutical companies to emerging biotechnology firms. The company operates as a Public Benefit Corporation.
The information is based on a press release statement from Veeva Systems.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- A.O. Smith executive chairman to retire, CEO to assume chairman role
- Jefferies Starts UzNIF (UZNF:LI) at Buy
- ZenaTech raises Plurilock Security stake to 12% with new share purchase
Create E-mail Alert Related Categories
Corporate NewsRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share